Upregulation of EMID1 Accelerates to a Favorable Prognosis and Immune Infiltration in Lung Adenocarcinoma

Table 3

EMID1 expression associated with clinical pathological characteristics (logistic regression).

Clinical characteristics	Total (N)	Odds ratio in EMID1 expression	-value
Gender (Male VS female)	522	0.66 (0.46,0.93)	0.019
Age ( ≥ 65 VS < 65)	522	0.75 (0.52,1.06)	0.105
Stage (II. VS I)	514	0.83 (0.54,1.27)	0.388
Stage (III. VS I)	514	0.52 (0.32,0.86)	0.012
Stage (IV. VS I)	514	0.30 (0.11,0.71)	0.009
Tumor status (T2 vs. T1)	519	0.79 (0.54,1.17)	0.242
Tumor status (T3 vs. T1)	519	0.50 (0.25,0.96)	0.041
Tumor status (T4 vs. T1)	519	0.47 (0.17,1.23)	0.132
Distant metastasis (M1 vs. M0)	378	0.37 (0.14,0.87)	0.030
Lymph node (N1 vs. N0)	510	0.92 (0.58,1.45)	0.705
Lymph node (N2 vs. N0)	510	0.49 (0.28,0.81)	0.007